Zymeworks Inc.
ZYMECIK 0001937653 · Every Form 4 filed by insiders at this issuer.
Filings
5
Latest Feb 9, 2024
Unique insiders
5
Showing
5 of 5
Page 1
Top insiders
Most active reporters at Zymeworks Inc.
| Name | Roles | Filings |
|---|---|---|
| Astle Christopher | Officer | 1 |
| Cesano Alessandra | Director | 1 |
| Galbraith Kenneth | OfficerDirector | 1 |
| Moore Paul Andrew | Officer | 1 |
| Smith Jeffrey T L | Officer | 1 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 9, 2024 | Cesano Alessandra Director | Holdings only | — | — | — | |
| Jan 8, 2024 | Smith Jeffrey T L EVP & Chief Medical Officer | Holdings only | — | — | — | |
| Jan 8, 2024 | Moore Paul Andrew Chief Scientific Officer | S | 7,460 | $10.6522 | $79,465 | |
| Jan 8, 2024 | Astle Christopher SVP & Chief Financial Officer | S | 4,563 | $10.6522 | $48,606 | |
| Jan 8, 2024 | Galbraith Kenneth Chair & CEO · Director | S | 18,198 | $10.6522 | $193,849 |
Showing 1–5 of 5
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.